
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors
Nutan Sharma, Lakhwinder Singh, Aditya Sharma, et al.
Pharmacological Research (2024) Vol. 208, pp. 107375-107375
Open Access | Times Cited: 3
Nutan Sharma, Lakhwinder Singh, Aditya Sharma, et al.
Pharmacological Research (2024) Vol. 208, pp. 107375-107375
Open Access | Times Cited: 3
Showing 3 citing articles:
Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study
Giuseppe Lisco, Davide Guido, Nicole Cerabino, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Giuseppe Lisco, Davide Guido, Nicole Cerabino, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Erk1R84H is an oncoprotein that causes hepatocellular carcinoma in mice and imposes a rigorous negative feedback loop
Nadine Soudah, Alexey Baskin, Merav Darash‐Yahana, et al.
Oncogene (2025)
Open Access
Nadine Soudah, Alexey Baskin, Merav Darash‐Yahana, et al.
Oncogene (2025)
Open Access
Identifying diagnostic biomarkers and predicting the role of Salvia miltiorrhiza compounds in hepatocellular carcinoma
Guang‐Bo Ge, Xiaohui Jiang, Xiaofeng Tian, et al.
Current Pharmaceutical Analysis (2025)
Open Access
Guang‐Bo Ge, Xiaohui Jiang, Xiaofeng Tian, et al.
Current Pharmaceutical Analysis (2025)
Open Access